Tuesday, February 15, 2011

Genzyme = Almost Done

Genzyme (Ticker: GENZ) moved up nicely today with the stock rising 3.53% on reports that the company has agreed to be acquired by Sanofi Aventis (Ticker: SNY) for $74 + CVR. The big question is the potential value of the CVR. We’ll find out in the merger agreement, which could be announced tomorrow morning. This news makes up for the Emergency Medical Services, Corp. (Ticker: EMS) take under in which shareholders were ripped off by the $300 million merger fee.


Post a Comment

<< Home